Interventional Cardiology

At Biosensors, we strive to make an impact in patients’ lives by continually investing in and developing pioneering medical technology. Being at the forefront of new and innovative solutions helps us respond to the changing needs of the interventional cardiology market. We are the first company to offer a commercially available abluminal drug-eluting stent with a biodegradable limus technology.
 

Drug-Eluting Stents
Bare Metal Stents
Balloon
Dilatation Catheters
Drug Coated Stents

CAUTION: The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.

Biosensors’ interventional cardiology products, including BioMatrix Flex™, BioMatrix NeoFlex™, BioMatrix™, Axxess™, BioFreedom™, Chroma™, BioStream™, BioPath™, Gazelle™, Juno™, S-Stent™, Powerline™, Quadrature Link™ and MultiPleat™, are not available for sale in the United States and certain other countries. All other trademarks are the property of their respective owners.

BioMatrix Flex, BioMatrix NeoFlex, BioMatrix, Axxess, BioFreedom, Chroma, BioStream, BioPath, Gazelle, Juno, S-Stent, Powerline, Quadrature Link and MultiPleat are trademarks or registered trademarks of Biosensors International Group, Ltd. in the United States and certain other countries. All cited trademarks are the property of their respective owners.